Stephen J. Galli - May 4, 2023 Form 4 Insider Report for ATOSSA THERAPEUTICS, INC. (ATOS)

Role
Director
Signature
/s/ Stephen J. Galli, M.D.
Stock symbol
ATOS
Transactions as of
May 4, 2023
Transactions value $
$0
Form type
4
Date filed
5/5/2023, 07:35 PM
Previous filing
May 16, 2022
Next filing
Jul 1, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATOS Stock Option (right to buy) Award $0 +125K $0.00 125K May 4, 2023 Common Stock 125K $0.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options shall vest on a quarterly basis over the next 12 months. The options were issued at approximately 9:50 a.m. (ET) on May 4, 2023, with an exercise price of $0.662, representing the most recently reported closing stock price on May 3, 2023.